Earnings Feed
Start Free
Home/Filings/4/0001012975-17-000071
4//SEC Filing

Heron Patrick J 4

Accession 0001012975-17-000071

CIK 0001370053other
View on SEC.govCompany Profile

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:20 PM ET

Size

39.8 KB

Accession

0001012975-17-000071

Insider Transaction Report

Form 4
Period: 2017-01-31
ANAPTYSBIO INCANAB
Frazier Healthcare VII, L.P.
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-01-31+209,095→ 209,095 total(indirect: See footnote)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+88,709$1,330,635→ 88,709 total(indirect: See footnote)
  • Conversion

    Series D Preferred Stock

    2017-01-31−733,740→ 0 total
    → Common Stock (733,740 underlying)
  • Conversion

    Common Stock

    2017-01-31+1,428,571→ 1,428,571 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+195,751→ 195,751 total(indirect: See footnote)
  • Conversion

    Series C Preferred Stock

    2017-01-31−604,055→ 0 total(indirect: See footnote)
    → Common Stock (604,055 underlying)
  • Conversion

    Common Stock

    2017-01-31+604,055→ 604,055 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+733,740→ 733,740 total
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+311,291$4,669,365→ 311,291 total
  • Conversion

    Series C-1 Preferred Stock

    2017-01-31−195,751→ 0 total(indirect: See footnote)
    → Common Stock (195,751 underlying)
  • Conversion

    Series B Preferred Stock

    2017-01-31−1,428,571→ 0 total(indirect: See footnote)
    → Common Stock (1,428,571 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−209,095→ 0 total(indirect: See footnote)
    → Common Stock (209,095 underlying)
Frazier Healthcare VII-A, L.P.
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-01-31+195,751→ 195,751 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+733,740→ 733,740 total
  • Conversion

    Common Stock

    2017-01-31+604,055→ 604,055 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+1,428,571→ 1,428,571 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+209,095→ 209,095 total(indirect: See footnote)
  • Conversion

    Series C Preferred Stock

    2017-01-31−604,055→ 0 total(indirect: See footnote)
    → Common Stock (604,055 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2017-01-31−195,751→ 0 total(indirect: See footnote)
    → Common Stock (195,751 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−733,740→ 0 total
    → Common Stock (733,740 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−209,095→ 0 total(indirect: See footnote)
    → Common Stock (209,095 underlying)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+311,291$4,669,365→ 311,291 total
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+88,709$1,330,635→ 88,709 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2017-01-31−1,428,571→ 0 total(indirect: See footnote)
    → Common Stock (1,428,571 underlying)
FHM VII, L.L.C.
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-01-31+195,751→ 195,751 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2017-01-31−1,428,571→ 0 total(indirect: See footnote)
    → Common Stock (1,428,571 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2017-01-31−195,751→ 0 total(indirect: See footnote)
    → Common Stock (195,751 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−733,740→ 0 total
    → Common Stock (733,740 underlying)
  • Conversion

    Series C Preferred Stock

    2017-01-31−604,055→ 0 total(indirect: See footnote)
    → Common Stock (604,055 underlying)
  • Conversion

    Common Stock

    2017-01-31+1,428,571→ 1,428,571 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+733,740→ 733,740 total
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+88,709$1,330,635→ 88,709 total(indirect: See footnote)
  • Conversion

    Series D Preferred Stock

    2017-01-31−209,095→ 0 total(indirect: See footnote)
    → Common Stock (209,095 underlying)
  • Conversion

    Common Stock

    2017-01-31+604,055→ 604,055 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+209,095→ 209,095 total(indirect: See footnote)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+311,291$4,669,365→ 311,291 total
FRAZIER ALAN D
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-01-31+604,055→ 604,055 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+195,751→ 195,751 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+209,095→ 209,095 total(indirect: See footnote)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+311,291$4,669,365→ 311,291 total
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+88,709$1,330,635→ 88,709 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2017-01-31−1,428,571→ 0 total(indirect: See footnote)
    → Common Stock (1,428,571 underlying)
  • Conversion

    Series C Preferred Stock

    2017-01-31−604,055→ 0 total(indirect: See footnote)
    → Common Stock (604,055 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−733,740→ 0 total
    → Common Stock (733,740 underlying)
  • Conversion

    Common Stock

    2017-01-31+733,740→ 733,740 total
  • Conversion

    Common Stock

    2017-01-31+1,428,571→ 1,428,571 total(indirect: See footnote)
  • Conversion

    Series C-1 Preferred Stock

    2017-01-31−195,751→ 0 total(indirect: See footnote)
    → Common Stock (195,751 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−209,095→ 0 total(indirect: See footnote)
    → Common Stock (209,095 underlying)
Naini Nader J
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-01-31+733,740→ 733,740 total
  • Conversion

    Common Stock

    2017-01-31+1,428,571→ 1,428,571 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+195,751→ 195,751 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+604,055→ 604,055 total(indirect: See footnote)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+88,709$1,330,635→ 88,709 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+209,095→ 209,095 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2017-01-31−1,428,571→ 0 total(indirect: See footnote)
    → Common Stock (1,428,571 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−733,740→ 0 total
    → Common Stock (733,740 underlying)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+311,291$4,669,365→ 311,291 total
  • Conversion

    Series C Preferred Stock

    2017-01-31−604,055→ 0 total(indirect: See footnote)
    → Common Stock (604,055 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2017-01-31−195,751→ 0 total(indirect: See footnote)
    → Common Stock (195,751 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−209,095→ 0 total(indirect: See footnote)
    → Common Stock (209,095 underlying)
Heron Patrick J
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-01-31+1,428,571→ 1,428,571 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+195,751→ 195,751 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+733,740→ 733,740 total
  • Conversion

    Series B Preferred Stock

    2017-01-31−1,428,571→ 0 total(indirect: See footnote)
    → Common Stock (1,428,571 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2017-01-31−195,751→ 0 total(indirect: See footnote)
    → Common Stock (195,751 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−733,740→ 0 total
    → Common Stock (733,740 underlying)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+88,709$1,330,635→ 88,709 total(indirect: See footnote)
  • Conversion

    Series D Preferred Stock

    2017-01-31−209,095→ 0 total(indirect: See footnote)
    → Common Stock (209,095 underlying)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+311,291$4,669,365→ 311,291 total
  • Conversion

    Series C Preferred Stock

    2017-01-31−604,055→ 0 total(indirect: See footnote)
    → Common Stock (604,055 underlying)
  • Conversion

    Common Stock

    2017-01-31+604,055→ 604,055 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+209,095→ 209,095 total(indirect: See footnote)
FHM VII, L.P.
10% Owner
Transactions
  • Conversion

    Series C Preferred Stock

    2017-01-31−604,055→ 0 total(indirect: See footnote)
    → Common Stock (604,055 underlying)
  • Conversion

    Common Stock

    2017-01-31+1,428,571→ 1,428,571 total(indirect: See footnote)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+311,291$4,669,365→ 311,291 total
  • Conversion

    Common Stock

    2017-01-31+604,055→ 604,055 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+733,740→ 733,740 total
  • Conversion

    Series B Preferred Stock

    2017-01-31−1,428,571→ 0 total(indirect: See footnote)
    → Common Stock (1,428,571 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2017-01-31−195,751→ 0 total(indirect: See footnote)
    → Common Stock (195,751 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−733,740→ 0 total
    → Common Stock (733,740 underlying)
  • Conversion

    Common Stock

    2017-01-31+195,751→ 195,751 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+209,095→ 209,095 total(indirect: See footnote)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+88,709$1,330,635→ 88,709 total(indirect: See footnote)
  • Conversion

    Series D Preferred Stock

    2017-01-31−209,095→ 0 total(indirect: See footnote)
    → Common Stock (209,095 underlying)
Every Nathan R
10% Owner
Transactions
  • Conversion

    Series C-1 Preferred Stock

    2017-01-31−195,751→ 0 total(indirect: See footnote)
    → Common Stock (195,751 underlying)
  • Conversion

    Common Stock

    2017-01-31+1,428,571→ 1,428,571 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+604,055→ 604,055 total(indirect: See footnote)
  • Conversion

    Common Stock

    2017-01-31+733,740→ 733,740 total
  • Conversion

    Common Stock

    2017-01-31+209,095→ 209,095 total(indirect: See footnote)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+88,709$1,330,635→ 88,709 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2017-01-31−1,428,571→ 0 total(indirect: See footnote)
    → Common Stock (1,428,571 underlying)
  • Conversion

    Series C Preferred Stock

    2017-01-31−604,055→ 0 total(indirect: See footnote)
    → Common Stock (604,055 underlying)
  • Conversion

    Series D Preferred Stock

    2017-01-31−733,740→ 0 total
    → Common Stock (733,740 underlying)
  • Conversion

    Common Stock

    2017-01-31+195,751→ 195,751 total(indirect: See footnote)
  • Purchase

    Common Stock

    2017-01-31$15.00/sh+311,291$4,669,365→ 311,291 total
  • Conversion

    Series D Preferred Stock

    2017-01-31−209,095→ 0 total(indirect: See footnote)
    → Common Stock (209,095 underlying)
Footnotes (7)
  • [F1]The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.
  • [F2]The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.
  • [F3]The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.
  • [F4]The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.
  • [F5]Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
  • [F6]Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
  • [F7]Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Documents

1 file

Issuer

ANAPTYSBIO INC

CIK 0001370053

→
Entity typeother

Related Parties

1
  • filerCIK 0001365617

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:20 PM ET
Size
39.8 KB
View on SEC.gov